NASDAQ:MYL - Mylan Stock Price, Forecast & News

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan NV (NASDAQ:MYL) announced its earnings results on Tuesday, November, 5th. The company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $1.14 by $0.03. The company earned $2.96 billion during the quarter, compared to the consensus estimate of $3.01 billion. Mylan had a return on equity of 18.80% and a net margin of 0.42%. The firm's revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.25 earnings per share. View Mylan's Earnings History.

Mylan is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Mylan.

20 brokerages have issued 12-month target prices for Mylan's stock. Their forecasts range from $18.00 to $36.00. On average, they anticipate Mylan's share price to reach $26.92 in the next twelve months. This suggests a possible upside of 29.0% from the stock's current price. View Analyst Price Targets for Mylan.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 9 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mylan.

News coverage about MYL stock has trended somewhat positive this week, according to InfoTrie. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mylan earned a media sentiment score of 0.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Mylan.

Mylan saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 22,280,000 shares, an increase of 13.2% from the January 15th total of 19,680,000 shares. Based on an average daily trading volume, of 6,652,600 shares, the days-to-cover ratio is presently 3.3 days. Currently, 4.3% of the company's shares are sold short. View Mylan's Current Options Chain.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Alibaba Group (BABA), Allergan (AGN), Micron Technology (MU), Starbucks (SBUX), Intel (INTC), Netflix (NFLX), NVIDIA (NVDA) and Pfizer (PFE).

Mylan's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.53%), Pzena Investment Management LLC (4.03%), AQR Capital Management LLC (1.80%), FIL Ltd (1.58%), Bank of New York Mellon Corp (0.97%) and Samlyn Capital LLC (0.80%). Company insiders that own Mylan stock include Anthony Mauro, Goulds Bruce, Melina E Higgins, Paul Campbell, Rajiv Malik, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Institutional Ownership Trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Phoenix Holdings Ltd., Banco Santander S.A., Schroder Investment Management Group, First Trust Advisors LP, Bank of New York Mellon Corp, Amundi Pioneer Asset Management Inc. and FMR LLC. View Insider Buying and Selling for Mylan.

MYL stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Jacobs Levy Equity Management Inc., Pzena Investment Management LLC, Samlyn Capital LLC, Marshall Wace North America L.P., Marshall Wace LLP, FIL Ltd and Schonfeld Strategic Advisors LLC. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Insider Buying and Selling for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $20.87.

Mylan has a market capitalization of $10.77 billion and generates $11.43 billion in revenue each year. The company earns $352.50 million in net income (profit) each year or $4.58 on an earnings per share basis. Mylan employs 35,000 workers across the globe.View Additional Information About Mylan.

The official website for Mylan is http://www.mylan.com/.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]